Literature DB >> 1717585

A conformational epitope expressed upon association of CD3-epsilon with either CD3-delta or CD3-gamma is the main target for recognition by anti-CD3 monoclonal antibodies.

A Salmerón1, F Sánchez-Madrid, M A Ursa, M Fresno, B Alarcón.   

Abstract

We have performed immunofluorescence analysis of COS cells transfected with human CD3 genes and detergent permeabilized to define the specificity of several anti-CD3 antibodies. We have found that the mAb OKT3, WT31, UCHT1, and Leu-4 did not stain COS cells singly transfected with the CD3-epsilon chain. However, these antibodies very strongly stained COS cells doubly transfected with a combination of CD3-epsilon plus either CD3-gamma or CD3-delta. By contrast, the antibodies SP34 and APA 1/1, which were raised against isolated SDS-denatured CD3-epsilon protein, gave a strong staining of COS cells singly transfected with CD3-epsilon as well as of the double transfectans. The recognition by this panel of anti-CD3 antibodies of CD3-gamma/epsilon and CD3-delta/epsilon complexes and not of CD3-epsilon alone was assessed by immunoprecipitation. These findings suggest that the most widely used mAb specific for the CD3 complex recognize conformational epitopes on CD3-epsilon, which are expressed when this chain is bound to either CD3-gamma or CD3-delta. It should also be highlighted that antibody WT31 clearly recognizes the CD3 moiety of the TCR/CD3 complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717585

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  CD3 and CD2 antigen-mediated CD3 gamma-chain phosphorylation in permeabilized human T cells. Regulation by cytosolic phosphatases.

Authors:  D R Alexander; M H Brown; A L Tutt; M J Crumpton; E Shivnan
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

2.  Crystal structure of the human T cell receptor CD3 epsilon gamma heterodimer complexed to the therapeutic mAb OKT3.

Authors:  Lars Kjer-Nielsen; Michelle A Dunstone; Lyudmila Kostenko; Lauren K Ely; Travis Beddoe; Nicole A Mifsud; Anthony W Purcell; Andrew G Brooks; James McCluskey; Jamie Rossjohn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

3.  Crystal structure of a human CD3-epsilon/delta dimer in complex with a UCHT1 single-chain antibody fragment.

Authors:  Kelly L Arnett; Stephen C Harrison; Don C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

4.  Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus Saimiri.

Authors:  H Fickenscher; C Bökel; A Knappe; B Biesinger; E Meinl; B Fleischer; B Fleckenstein; B M Bröker
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 5.  Targeting of peripheral blood T lymphocytes.

Authors:  R L Bolhuis; H R Hoogenboom; J W Gratama
Journal:  Springer Semin Immunopathol       Date:  1996

6.  Anti-TCRβ mAb induces long-term allograft survival by reducing antigen-reactive T cells and sparing regulatory T cells.

Authors:  Y Miyahara; M Khattar; P M Schroder; B Mierzejewska; R Deng; R Han; W W Hancock; W Chen; S M Stepkowski
Journal:  Am J Transplant       Date:  2012-03-15       Impact factor: 8.086

7.  Monoclonal antibodies that identify the CD3 molecules expressed specifically at the surface of porcine gammadelta-T cells.

Authors:  Huaizhi Yang; R Michael E Parkhouse; Thomas Wileman
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

8.  Expression of functional molecules by human CD3- decidual granular leucocyte clones.

Authors:  L Gudelj; G Deniz; D Rukavina; P M Johnson; S E Christmas
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

9.  Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects.

Authors:  Ivan Stratov; Amy Chung; Stephen J Kent
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

Review 10.  Mechanistic basis of immunotherapies for type 1 diabetes mellitus.

Authors:  Wenhao Chen; Aini Xie; Lawrence Chan
Journal:  Transl Res       Date:  2013-01-22       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.